David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
STAAR Surgical
STAA
$1.17B
| $12.8M | 0.02% |
411,400
+327,625
| +391% | +$7.67M |
|
927
Carvana
CVNA
$79.5B
| $12.7M | 0.02% |
1,530,820
+1,225,230
| +401% | +$7.38M |
|
|
APTI
928
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $12.7M | 0.02% |
350,891
+158,131
| +82% | +$5.08M |
|
929
GDS Holdings
GDS
$6.36B
| $12.7M | 0.02% |
316,699
-41,403
| -12% | -$1.42M |
|
930
CALL
Berkshire Hathaway Class B
BRK.B
$1.08T
| $12.7M | 0.02% |
68,000
+13,000
| +24% | +$2.53M |
|
931
Hancock Whitney
HWC
$6.01B
| $12.7M | 0.02% |
271,885
+153,728
| +130% | +$7.8M |
|
932
General Mills
GIS
$21.9B
| $12.7M | 0.02% |
286,156
+34,631
| +14% | +$1.52M |
|
933
Cintas
CTAS
$83B
| $12.6M | 0.02% |
273,300
-145,476
| -35% | -$6.55M |
|
934
ManpowerGroup
MAN
$2.86B
| $12.6M | 0.02% |
+146,566
| New | +$14.4M |
|
935
Progress Software
PRGS
$1.78B
| $12.6M | 0.02% |
324,637
+97,682
| +43% | +$3.71M |
|
936
CALL
Sarepta Therapeutics
SRPT
$1.92B
| $12.6M | 0.02% |
95,200
+35,200
| +59% | +$3.32M |
|
937
Dolby
DLB
$6.19B
| $12.6M | 0.02% |
203,928
-217,787
| -52% | -$13.9M |
|
938
Option Care Health
OPCH
$3.55B
| $12.6M | 0.02% |
1,071,672
-29,610
| -3% | -$310K |
|
|
PXD
939
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $12.5M | 0.02% |
66,300
-4,100
| -6% | -$785K |
|
940
Stride
LRN
$3.54B
| $12.5M | 0.02% |
766,127
-88,102
| -10% | -$1.37M |
|
941
JetBlue
JBLU
$1.87B
| $12.5M | 0.02% |
659,220
+165,489
| +34% | +$3.19M |
|
|
GCP
942
DELISTED
GCP Applied Technologies Inc.
GCP
| $12.5M | 0.02% |
432,036
+79,460
| +23% | +$2.4M |
|
943
Oshkosh
OSK
$9.65B
| $12.5M | 0.02% |
177,102
+5,648
| +3% | +$422K |
|
944
PUT
Prudential Financial
PRU
$42.3B
| $12.4M | 0.02% |
132,600
+87,700
| +195% | +$8.86M |
|
|
AUD
945
DELISTED
Audacy, Inc.
AUD
| $12.4M | 0.02% |
1,640,568
-955,720
| -37% | -$8.1M |
|
946
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.23B
| $12.3M | 0.02% |
163,510
+500
| +0.3% | +$38.2K |
|
947
Knowles
KN
$2.78B
| $12.3M | 0.02% |
803,053
-126,243
| -14% | -$1.74M |
|
948
Idexx Laboratories
IDXX
$44.1B
| $12.3M | 0.02% |
56,336
+18,790
| +50% | +$3.87M |
|
949
PUT
IPG Photonics
IPGP
$3.01B
| $12.2M | 0.02% |
55,500
-34,800
| -39% | -$8.21M |
|
950
Boston Beer
SAM
$1.95B
| $12.2M | 0.02% |
40,783
+10,540
| +35% | +$2.57M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.